By Trend News Line 2024-05-08 16:45:39.
The Fight Against Cancer Continues
Researchers at the University of Central Florida (UCF) have joined forces with the Johns Hopkins Kimmel Cancer Center in a collaborative effort to combat pediatric brain tumors. Sudipta Seal, a professor and Chair of the Materials Science and Engineering Department at UCF, along with his postdoctoral researcher Elayaraja Kolanthai, have developed a groundbreaking solution containing therapeutic cerium oxide nanoparticles. This solution acts as a protective vehicle to deliver a combination of cancer therapies directly to the patient’s brain.
A Targeted Approach to Treatment
The innovative medicine developed by the Johns Hopkins team targets a specific part of RNA that plays a crucial role in promoting cancerous growth. By combining a genetic treatment with cisplatin, a common chemotherapy medication, the researchers were able to inhibit tumor growth by 40-50% in mice. This targeted approach shows promise as an alternative therapy to traditional treatments, with potentially fewer side effects and a lower risk of relapse.
Safe Delivery of Promising Treatments
Seal’s cerium oxide nanoparticles play a vital role in protecting and delivering the combination of therapies to the site of the brain tumor. By attaching various drugs to the nanoparticles, the researchers can ensure that the medications reach their intended target with precision. The cerium oxide nanoparticles have previously shown efficacy in healing diabetic wounds and maintaining bone strength during cancer treatments. Their versatility and compatibility with other compounds make them an ideal vehicle for delivering therapeutic interventions.
Collaboration and Continued Research
Seal and Perera’s collaboration on this pediatric cancer research highlights the power of interdisciplinary teamwork in the fight against cancer. The researchers are encouraged by the promising results of their study and are excited to explore other ways to utilize cerium oxide nanoparticles in biomedical applications. They invite other researchers to collaborate and explore the potential of this innovative technology in treating various medical conditions.
Hope for the Future
Funded by the National Institutes of Health and the National Cancer Institute, the researchers are optimistic about the potential of their therapy in treating pediatric cancer. They plan to conduct further studies in humans to evaluate the safety and efficacy of the treatment. With the ultimate goal of providing relief for children with cancer, the researchers are dedicated to advancing their research and making a meaningful impact in the fight against this devastating disease.
Researcher’s Background
Seal’s extensive background in materials engineering and biochemistry, combined with his experience in nanotechnology, has positioned him as a leading expert in the field. With a focus on developing innovative solutions for medical interventions, Seal’s research has the potential to revolutionize the way we approach cancer treatment. His dedication to advancing scientific knowledge and improving patient outcomes underscores the importance of collaboration and innovation in the fight against cancer.
.
1. UCF Researcher’s Nanoparticles Serve as Pivotal Delivery Component of Promising Pediatric Cancer Treatment
2. UCF Researcher’s Nanoparticles Serve as Pivotal Delivery Component of Pediatric Cancer Treatment.